Advertisement

Picture EBD Group BIO-Europe Spring 2025 Milan to 28 Feb 650x100px
Organisation › Details

EG 427 (FR, Pinpoint Gene Therapy)

EG 427 has developed a unique, non-replicative Herpes Simplex Virus type 1 (nrHSV-1) based vector platform. It delivers, with pinpoint precision, highly selective, durable expression of disease modifying transgenes. We take advantage of it to design new treatments of peripheral nervous system disorders and beyond. Our lead asset, EG110A, targets the silencing of type-C sensory neurons. It is first being developed in urology indications. Our earlier stage products are focused on modifying the neurotransmission of other subsets of neurons. Furthermore, we are building the necessary manufacturing efficiency to bring genomic medicine to more prevalent, high medical need indications. Our HQ and labs are located in Paris, France. *

 

Period Start 2019-05-31 established
Period End 2021-01-01 renamed approx
  Predecessor Genelpis SAS
Product Industry gene therapy
Persons Person Chambon, Philippe (EG 427 202103 CEO + LBO France 201811)
  Person 2 Lamond, David (En Pointe LLC 202103 President)
     
Region Region Paris
  Country France
  Street 29 rue du Faubourg Saint-Jacques
  City 75014 Paris
    Address record changed: 2023-07-19
     
Basic data Employees n. a.
     
    * Document for »About Section«: EG 427. (7/13/23). "Press Release: EG 427 Announces Final Series A Closing, Achieving €18 Million in Total Funds Raised". Paris.
     
   
Record changed: 2024-06-07

Advertisement

Picture EBD Group ChinaBio Partnering Forum 2025 Shanghai 650x200px

More documents for EG 427 (FR, Pinpoint Gene Therapy)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Berlin Partner Events RegMed Forum 2025 HealthCapital 650x300px




» top